Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail
-

Slides for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
 
FDA Core Presentations, EGRIFTA (Tesamorelin acetate), NDA 22-505, for the May 27, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee:
 
 
 
 
Sponsor
 
 
-
-